Simon Fitall

Pharma Commercial Analytics Two core questions that constantly come up in pharma commercial analytics: How big, and what is the profile of our patient population? How many patients are there…

Executing smart marketing and sales tactics requires deep knowledge of the target – here’s how Galileo Cosmos™ patient flow analytics facilitates that process... Key Principles Tactical execution of sales and…

Building commercial coherence from strategy to tactics requires integrated data analysis – here’s how Galileo Cosmos™ facilitates that process... Key Principles Strategic planning is the bedrock on which all product…

“Later-line” products are those products that are launched with a label that requires that other treatments be tried before they are prescribed. Forecasting them is a challenge. Key Principles Forecasting…

Using data to help manage solutions Almost patient involved in the opioid crisis starts their use because of a genuine medical need. Chronic pain due to a long term condition,…

In recent years the number of adverse events being reported through the FDA Adverse Event Reporting System (FAERS) has generally increased as a result of broader reporting requirements and greater…

Complex patient analysis – discovering the patient cohorts that make the difference (part 3) Patients are very complex things to analyse and unfortunately most of our analyses don’t touch on…